MOLOGEN AG / Key word(s): Capital Increase 30.03.2015 20:44 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- MOLOGEN AG fixes subscription price for capital increase at EUR 5.00 Berlin, 30 March 2015 - Today, the executive board of MOLOGEN AG (ISIN DE0006637200/WKN 663720) fixed, with the approval of the supervisory board, the subscription price for the capital increase against contributions in cash with indirect subscription rights for existing shareholders resolved on 24 March 2015 at EUR 5.00. The company expects that the German Financial Supervisory Authority (BaFin) will probably approve securities prospectus with comprehensive information on and risk factors relating to the subscription offer in the course of 31 March 2015. Following such approval by BaFin, the company will publish the securities prospectus on the website of MOLOGEN AG without undue delay. DISCLAIMER This announcement does not constitute an offer to buy shares or other securities of MOLOGEN AG and does not replace the prospectus. Investment decisions with respect to the shares or other securities of MOLOGEN AG shall only take place on the basis of the prospectus which will be available after the approval by the German Financial Supervisory Authority (BaFin) free of charge at MOLOGEN AG. This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, securities to any person in the United States of America (the "United States"), Australia, Canada or Japan or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The securities referred to in this announcement will not be and have not been registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act") and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements under the U.S. Securities Act. Subject to certain exceptions, the securities referred to in this announcement may not be offered or sold in Australia, Canada or Japan, or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan. The offer and sale of the securities referred to in this announcement has not been and will not be registered under the U.S. Securities Act or under the applicable securities laws of Australia, Canada or Japan. There will be no public offer of the securities in the United States. --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: Contact Claudia Nickolaus Head of Investor Relations & Corporate Communications Tel: +49 - 30 - 84 17 88 - 38 Fax: +49 - 30 - 84 17 88 - 50 investor@mologen.com 30.03.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: MOLOGEN AG FabeckstraÃe 30 14195 Berlin Germany Phone: 030 / 841788-0 Fax: 030 / 841788-50 E-mail: presse@mologen.com Internet: www.mologen.com ISIN: DE0006637200 WKN: 663720 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: MOLOGEN AG fixes subscription price for capital increase at EUR 5.00
| Source: EQS Group AG